Microbix’s Clot-Buster Drug Project Advances
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq futures fall as oil prices jump, key earnings loom
- Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| (NASDAQ: MBX) | Delayed: 52.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.48 | 52 Week High | $ | |||
| Open | $52.48 | 52 Week Low | $ | |||
| Day High | $52.48 | P/E | N/A | |||
| Day Low | $52.48 | EPS | $ | |||
| Volume | 2,678 | |||||
| Microbix Biosystems, Inc. (AMEX: MBXBF) | Delayed: 0.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $0.28 | |||
| Open | $0.22 | 52 Week Low | $0.14 | |||
| Day High | $0.22 | P/E | N/A | |||
| Day Low | $0.22 | EPS | $0.00 | |||
| Volume | 79 | |||||
